文献速递贫血与红细胞疾病白血病MDS 与骨髓增殖性肿瘤

Nlrp3炎症小体作为正常与恶性造血研究中的「新星」

The Nlrp3 inflammasome as a "rising star" in studies of normal and malignant hematopoiesis.
PubMed 文献 · Leukemia · 2020-04-20

本综述指出造血受先天免疫信号调控,Nlrp3炎症小体是整合微环境变化、细胞活化与代谢活性的关键因子。文章总结其在造血干祖细胞发育、应激及药物动员后释放、移植后归巢、衰老与代谢调控中的作用,并涉及骨髓增生异常综合征、骨髓增殖性肿瘤、白血病及移植后移植物抗宿主病等血液病理。

要点

  • Nlrp3炎症小体是造血与淋系细胞中研究最充分的炎症小体家族成员。
  • 其参与造血干祖细胞发育扩增、应激与药物动员后释放、移植后归巢、衰老及代谢调控。
  • 其亦涉及骨髓增生异常综合征、骨髓增殖性肿瘤、白血病及移植后移植物抗宿主病。

核心结论

  • Nlrp3炎症小体在正常稳态与病理造血研究中已成为「新星」,本综述旨在对其作进一步阐明。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • Nlrp3炎症小体被认为是感知机体微环境变化、细胞活化与细胞代谢活性的主要传感器。
  • 其是造血与淋系细胞(包括造血干祖细胞)中表达且研究最充分的炎症小体家族成员。
  • 其被提出参与造血干祖细胞的发育与扩增。
  • 其被提出参与应激状态及药物动员时造血干祖细胞从骨髓释放至外周血。
  • 其被提出参与移植后造血干祖细胞归巢至骨髓、衰老及造血细胞代谢调控,并涉及骨髓增生异常综合征、骨髓增殖性肿瘤、白血病及移植后移植物抗宿主病。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent investigations indicate that hematopoiesis is coregulated by innate immunity signals and by pathways characteristic of the activation of innate immunity cells that also operate in normal hematopoietic stem progenitor cells (HSPCs). This should not be surprising because of the common developmental origin of these cells from a hemato/lymphopoietic stem cell. An important integrating factor is the Nlrp3 inflammasome, which has emerged as a major sensor of changes in body microenvironments, cell activation, and cell metabolic activity. It is currently the best-studied member of the inflammasome family expressed in hematopoietic and lymphopoietic cells, including also HSPCs. It is proposed as playing a role in (i) the development and expansion of HSPCs, (ii) their release from bone marrow (BM) into peripheral blood (PB) in stress situations and during pharmacological mobilization, (iii) their homing to BM after transplantation, and (iv) their aging and the regulation of hematopoietic cell metabolism. The Nlrp3 inflammasome is also involved in certain hematological pathologies, including (i) myelodysplastic syndrome, (ii) myeloproliferative neoplasms, (iii) leukemia, and (iv) graft-versus-host disease (GvHD) after transplantation. The aim of this review is to shed more light on this intriguing intracellular protein complex that has become a "rising star" in studies focused on both normal steady-state and pathological hematopoiesis.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Ratajczak MZ, Bujko K, Cymer M, et al. The Nlrp3 inflammasome as a "rising star" in studies of normal and malignant hematopoiesis. Leukemia. 2020. PMID: 32313108. doi:10.1038/s41375-020-0827-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。